- Home
- SOS vs DYAI Comparison
SOS vs DYAI Comparison
Compare SOS & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SOS | DYAI |
|---|---|---|
| Founded | 2004 | 1979 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.9M | 17.0M |
| IPO Year | 2005 | 2026 |
Fundamental Metrics
Financial Performance| Metric | SOS | DYAI |
|---|---|---|
| Price | $0.21 | $0.41 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 131.5K |
| Earning Date | 10-07-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,090,345.00 |
| Revenue This Year | N/A | $113.16 |
| Revenue Next Year | N/A | $94.92 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.19 | $0.34 |
| 52 Week High | $2.08 | $1.60 |
Technical Indicators
Market Signals| Indicator | SOS | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 21.81 | 33.95 |
| Support Level | N/A | $0.34 |
| Resistance Level | $1.07 | $0.50 |
| Average True Range (ATR) | 0.03 | 0.04 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 6.18 | 12.36 |
Price Performance
Historical ComparisonAbout SOS SOS Limited
SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing and other Hosting services. The company has single reporting segment: Commodity trading and generates key revenue is generated from Commodity trading.
About DYAI Dyadic International Inc.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.